Key result
Hypomagnesemia increases the risk of sudden cardiac death, unstable angina, and cardiovascular mortality in women, and magnesium supplementation may help prevent and treat these conditions.
Why the study?
Does magnesium supplementation improve cardiovascular and reproductive outcomes in women?
Does magnesium supplementation improve cardiovascular and reproductive outcomes in women?
This review highlights the importance of magnesium in women's cardiovascular health and suggests a role for magnesium supplementation in preventing and treating heart disease.
Supports hypothesis-generating role for magnesium in women's CV health; leaves open need for RCTs before any practice change.
Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system in women is summarized. Evidence-based medicine data has shown a link between magnesium blood (plasma, red blood cells) levels and increased risk of somatic diseases in women of reproductive age. Hypomagnesemia increases the risk of sudden cardiac death, unstable angina, and cardiovascular mortality due to myocardial tissue functional disorders, mitochondrial failure. Magnesium ions are essential for maintaining the physiological pregnancy. Experimental and clinical data allows using drugs of magnesium in preventing and treating heart disease in women. Their use is also possible for treatment of gynecological diseases, for pregnant women with arterial hypertension and connective tissue dysplasia.
No takes yet. Share an insight, caveat, or question.
Ulubieva et al. (2016) conducted a review in Cardiovascular and reproductive system diseases. Magnesium was evaluated. Hypomagnesemia increases the risk of sudden cardiac death, unstable angina, and cardiovascular mortality in women, and magnesium supplementation may help prevent and treat these conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: